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Abstract
Background: Previous studies examined midlife risk factors separately for old-age impaired physical and cognitive functioning. We determined 
the overlap of risk factors for both domains of functioning within the same setting.
Methods: Biological and behavioral risk factors at age 50 years and cognitive and physical functioning were assessed 18 (SD = 5) years later 
in the Whitehall II study (N = 6,316). Impaired physical functioning was defined as ≥1 limitation on the activities of daily living scale. Impaired 
cognitive functioning was defined as Mini-Mental State Examination score <27. Two statistical analyses were employed: minimally adjusted 
analysis (for age, sex, and ethnicity) and mutually adjusted analysis (including all risk factors). Missing data on risk factors were imputed.
Results: After confounder adjustment, impaired physical and cognitive functioning at older ages were predicted by hypertension (odds ratios 
[ORs] 1.80 95% confidence interval [CI] 1.39–2.33 and 1.57 95% CI 1.07–2.31, respectively), poor lung function (1.51 95% CI 1.28–1.78 
and 1.31 95% CI 1.08–1.59), and physical inactivity, marginally in the case of cognitive function (1.50 95% CI 1.19–1.90 and 1.27 95% CI 
0.99–1.62) at age 50 years. Impaired physical functioning but not cognitive functioning was additionally predicted by depression and higher 
body mass index (1.72 95% CI 1.46–2.03 and 1.29 95% CI 1.16–1.44, respectively).
Conclusions: Several midlife risk factors are associated with impaired physical and cognitive functioning in old age, supporting a unified 
prevention policy. Analysis of 12 risk factors at age 50 suggests that strategies targeting physical inactivity, hypertension, and poor lung 
function will reduce impairments in both cognitive and physical functioning in old age.
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An important policy goal in respect of healthy aging is to increase 
disability-free life expectancy and compress age-related morbidity 
into a short period before death (1). Several modifiable risk factors, 
including midlife raised blood pressure (2) and physical inactivity 
(3), have been identified for clinical management to reduce or delay 
impaired physical or cognitive functioning, but few studies have 
examined the extent to which such factors affect both physical and 
cognitive domains of functioning.
To inform research, the World Health Organization proposed the 
International Classification of Functioning, Disability and Health 
(ICF) (4), which synthesizes the medical and social conceptual mod-
els of disability and combines the individual and environmental 
dimensions of disablement within a unified biopsychosocial frame-
work. Broadly, impairment arises when physiological or cognitive 
problems occur, resulting in activity limitation. Previous studies have 
examined risk factors either for impaired physical functioning or for 
impaired cognitive functioning (5–8), but did not identify predictors 
of both types of functional loss. Consequently, the associations of 
several putative risk factors which affect these two domains of func-
tioning remain unclear.
To address this gap in the evidence, associations of 12 modifiable 
behavioral and biomedical risk factors at age 50 years with future 
impaired physical and cognitive functioning were assessed 18 (SD = 
5) years later among participants in the Whitehall II study.
Methods
Data Source
We analyzed data from the Whitehall II study (9). The study started 
in 1985 and included 10,308 civil servants aged 35–55 years, with 
repeated data collection every 2–3 years. Participants completed a 
health and lifestyle questionnaire at each data collection and under-
went a clinical screening at alternate assessments.
Outcome Definitions
We defined impaired physical functioning according to the activities 
of daily living (ADL) scale (10), measuring difficulties with six self-
care tasks: dressing, walking across the room, bathing or shower-
ing, eating, getting in or out of bed, and using the toilet. The ADL 
scale corresponds to the ICF model activity domain (Supplementary 
Figure 1). We defined impaired physical functioning as at least one 
limitation on the ADL scale. We defined impaired cognitive function 
using the Mini-Mental State Examination (MMSE) (11). The MMSE 
belongs to the ICF model body function and structure domain. The 
range of MMSE scale is 0–30. We dichotomized MMSE to indicate 
impaired cognitive functioning if MMSE score is less than 27 (12).
We identified the first occurrence for impaired physical and cog-
nitive functioning separately at either the fifth (2007–2009) or the 
sixth clinic (2012–2013). We investigated the outcome definitions by 
plotting the distribution of both outcome measures by sex.
Risk Factors
We extracted risk factors recorded during data collection when 
participants were aged 50  years, or the closest collection within 
±5 years. If age 50 years was exactly in between two data collections, 
we selected the one that included a clinical screening.
Nonmodifiable risk factors, from the ICF personal factors domain 
(Supplementary Figure 1), were as follows: age at impaired physical 
or cognitive functioning, time from age 50 to impaired physical or 
cognitive functioning, sex, ethnicity, marital status at age 50 years, 
highest ever academic qualification, and last known employment 
grade (equivalent to civil service grade if no longer employed at civil 
service).
Modifiable behavioral risk factors at age 50 years, from the ICF 
personal factors domain, were as follows: daily fruit and vegetable 
consumption (1+ portions/day), smoking status (current, ex, or never 
smoker), alcohol consumption (none, moderate [women 1–14, men 
1–21 units/week], or heavy [women ≥ 15, men ≥22 units/week] con-
sumption), and average hours of sleep on a weeknight dichotomized 
as normal (7–8 average hours on a weeknight) or abnormal. Physical 
activity (13) was categorized as “sufficiently active” (≥2.5 hours/
week moderate or ≥1 hour/week vigorous physical activity), “inac-
tivity” (<1 hour/week moderate and <1 hour/week vigorous physical 
activity), or “moderately active” (if not active or inactive).
From the ICF health condition domain at age 50  years, we 
identified externally verified stroke and myocardial infarction, and 
depression if the 30-item General Health Questionnaire identified 
depressive symptoms (14).
We investigated modifiable biomedical risk factors at age 
50 years from the body function and structure domain. The follow-
ing risk factors were derived from measures recorded during the 
clinic: body mass index (BMI [kg m−2]), also dichotomized to create 
an obese group (BMI ≥ 30kg m−2), hypertension (systolic blood pres-
sure ≥ 140 mmHg, diastolic blood pressure ≥ 90 mmHg, or reporting 
antihypertensive drug treatment), total:high-density lipoprotein cho-
lesterol ratio, fasting glucose (mmol L−1), forced expiratory volume 
in 1 second (FEV1, L), and C-reactive protein (CRP) level (mg L
−1). 
FEV1 was first measured at the fourth clinic (2002–2004) based on 
standardized methods (15). We used the largest FEV1 value from 
three maneuvers. Lung volumes are related to body size, and stand-
ing height is the most important correlating variable, so we corrected 
FEV1 for height by dividing by the square of the participant’s stand-
ing height and multiplying by the square of the sample mean height, 
1.77 m in men and 1.63 m in women (16), to ensure observed varia-
tion in lung function was due to factors other than body size.
Statistical Analysis
The study sample was defined as those who participated at the fifth 
(2007–2009) or sixth (2012–2013) clinic and who provided ADL 
and MMSE data. We summarized risk factors at age 50  years by 
outcome category. We used χ2 tests to test for heterogeneity of preva-
lence in each exposure group. We imputed missing risk factor data 
using multiple imputation which replaces missing values with ran-
domly selected draws from the missing data distribution conditional 
on the observed data, specified by an imputation model, creating 
multiple imputed data sets (17). Multiple imputation accounts for 
uncertainty due to missing data and obtains unbiased estimates and 
standard errors if the missing at random assumption is plausible, that 
is, the reason for the missing data is associated with observed, but 
not with unobserved, data (17). The imputation model included the 
risk factors described earlier, impaired physical and cognitive func-
tioning outcomes, and the following auxiliary variables measured 
at age 50 years, associated with at least one risk factor with missing 
data (18): data wave when participant was aged 50 years, angina or 
chest pain, antihypertensive drugs, mild exercise, satisfaction with 
standard of living, employment status, family history of high blood 
pressure, angina, diabetes, myocardial infarction or stroke, dias-
tolic blood pressure, waist circumference, forced vital capacity, and 
diabetes status. Additionally, for repeatedly measured variables, we 
included observed measurements from adjacent data collections to 
age 50 years. We imputed missing values with 10 cycles to generate 
20 imputed data sets, analyzed separately, and combined the results 
using Rubin’s rules (17).
We fitted logistic regression models for impaired physical and 
cognitive functioning, respectively, to estimate the associations 
between each risk factor at age 50 years and each binary old-age 
functioning outcome. We initially adjusted for age, sex, and ethnic-
ity and then mutually adjusted for all modifiable and nonmodifi-
able risk factors at age 50 years. BMI and obesity (BMI ≥ 30) were 
fitted in separate alternative models. We used Cochran’s Q test to 
examine heterogeneity of coefficients. As a sensitivity analysis, we 
compared the analysis of multiply imputed data with the last obser-
vation carried forward (LOCF) method: replacing missing values 
with the closest recorded value before age 50 (or if missing, after age 
50), excluding participants who still had missing values. We assumed 
participants without ethnicity data were White. Analyses were per-
formed using Stata 13.1.
Results
Of the original cohort, 9,354 were alive at the fifth clinic, of whom 
7,018 (70.9%) participated at the fifth or sixth clinic. We excluded 
638 participants with missing physical or cognitive functioning 
data and 64 participants lacking baseline data at age 50 ± 5  years. 
The analytic sample consisted of 6,316 individuals (90.0% of par-
ticipants): 980 (15.5%) with impaired physical functioning and 
927 (14.7%) with impaired cognitive functioning (MMSE < 27). 
238 Journals of Gerontology: MEDICAL SCIENCES, 2017, Vol. 72, No. 2
Of these, 97 (10.5%) had an MMSE score of less than 24. The distri-
bution of both outcome measures showed that a reasonable number 
of participants had impaired physical functioning and impaired cog-
nitive functioning using these definitions (Supplementary Figure 2). 
We showed distributions of impaired physical and cognitive function-
ing for the whole cohort as these distributions were similar for male 
and female participants. ADL data were not available at baseline 
because the questionnaire was added to the protocol when partici-
pants were aged 55 years or older. Among the small number of par-
ticipants in the baseline data who completed the MMSE, few scored 
less than 27 (n = 2/75, 2.7%). Length of follow-up for physical and 
cognitive functioning was mean 18.3 (SD = 5.2) and 18.6 (SD = 5.1) 
years, respectively, with minimum follow-up time of 4.9 years.
Demographic and socioeconomic (nonmodifiable) risk factors 
were associated with impaired physical and cognitive functioning 
(Table  1). Participants in higher civil service grades were higher 
functioning compared with their lower grade counterparts. All non-
modifiable risk factors at age 50 were significantly associated with 
both impaired physical and cognitive functioning, except ethnicity, 
marital status, and highest academic qualification.
Several health behaviors and biomedical risk factors at age 
50  years were associated with impaired physical and cognitive 
functioning (Supplementary Table 1). Physical activity, current smok-
ing, low fruit and vegetable consumption, hypertension, and lower 
FEV1 were each associated with both types of functional impairment.
In minimally adjusted models, we included age, sex, and ethnic-
ity. Impaired physical and cognitive functioning at follow-up were 
predicted by physical inactivity, hypertension, and lower FEV1 at 
age 50  years, for example, physical inactivity predicted impaired 
cognitive function, odds ratio (OR) 1.52 95% confidence interval 
(CI) 1.21–1.91 (Supplementary Tables 2 and 3 and Supplementary 
Figure 3). There was no evidence of heterogeneity in these risk fac-
tor effects. Impaired physical functioning, but not impaired cogni-
tive functioning, was predicted by fruit and vegetable consumption, 
current smoking, sleep duration, depression, obesity/higher BMI, 
total:high-density lipoprotein cholesterol ratio, fasting glucose, and 
serum CRP at age 50 years, with heterogeneity of risk factor effects 
being evident for depression, obesity/higher BMI, fasting glucose, 
and serum CRP.
In mutually adjusted analysis, physical inactivity, hypertension, 
and low FEV1 at age 50 years remained risk factors for both out-
comes at follow-up, although the association of physical inactivity 
with cognitive impairment was borderline (Figure  1). This asso-
ciation was significant when adjusted for other health behaviors 
Table  1. Prevalence of Impaired Physical and Cognitive Functioning at Time of Outcome Measurement (2007–2009 or 2012–2013) by 
Nonmodifiable Participant Characteristics (with row percentages)
Impaired Physical Functioning 
(n = 980)
Impaired Cognitive Functioning 
(n = 927)
Total (N = 6,316) n (%) p Valuea n (%) p Valuea
Age group (years) at time of outcome measurement
 55–64 1,795/1,802b 277 (15.4) <.001 175 (9.7) <.001
 65–69 1,834/1,855 231 (12.6) 213 (11.5)
 70–74 1,375/1,390 242 (17.6) 271 (19.5)
 75–79 1,092/1,042 194 (17.8) 229 (22.0)
 80+ 220/227 36 (16.4) 39 (17.2)
Sex
 Male 4,516 653 (14.5) <.001 603 (13.4) <.001
 Female 1,800 327 (18.2) 324 (18.0)
Ethnicityc
 White 5,809 895 (15.4) .655 701 (12.1) <.001
 South Asian 292 50 (17.1) 129 (44.2)
 Black 160 29 (18.1) 84 (52.5)
 Missing 10 0 (0.0) 2 (20.0)
Marital status at age 50 years
 Married/cohabiting 4,736 676 (14.3) <.001 686 (14.5) .207
 Single 752 144 (19.1) 114 (15.2)
 Divorced/widowed 512 108 (21.1) 89 (17.4)
 Missing 316 52 (16.5) 38 (12.0)
Highest ever academic qualification
 Degree 2,520 336 (13.3) <.001 280 (11.1) <.001
 School 3,052 494 (16.2) 462 (15.1)
 None 463 100 (21.6) 130 (28.1)
 Missing 281 50 (17.8) 55 (19.6)
Last known grade
 1–2 (High) 2,717 359 (13.2) <.001 217 (8.0) <.001
 3–5 2,798 447 (16.0) 418 (14.9)
 6 (Low) 801 174 (21.7) 292 (36.5)
Notes: Impaired physical functioning—at least one activity of daily living. Impaired cognitive functioning—Mini-Mental State Examination score <27. Some 
participants have both impaired physical and cognitive functioning.
aχ2 test for heterogeneity of prevalence in each exposure group.
bThe figures in the age group total column are totals for impaired physical functioning and impaired cognitive functioning respectively.
cForty-five participants with “other” ethnicity.
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(as well as demographics) but not for biomedical factors (OR 1.29 
95% CI 1.02–1.63; Supplementary Table 4). Compared with mini-
mally adjusted analysis, fewer modifiable risk factors at age 50 years 
were associated with impaired physical functioning in the mutually 
adjusted models. We found heterogeneity for the depression and 
BMI coefficients with impaired physical, but not with impaired cog-
nitive, functioning associated with depression and higher BMI (ORs 
respectively 1.72 95% CI 1.46–2.03 and 1.29 95% CI 1.16–1.44) 
in the mutually adjusted analysis (Supplementary Tables 2 and 3).
Hypertension was associated with an increase in the preva-
lence of both impaired physical and cognitive functioning of about 
5% from 14% in those without hypertension whereas sufficiently 
active, compared with inactive, participants had more than 10% 
lower prevalence of impaired physical and cognitive functioning 
(Supplementary Table 1). In addition, the 20% of participants with 
the lowest FEV values had a prevalence of impaired physical and 
cognitive functioning of 21% and 23% respectively, compared with 
the other 80% of participants who had a prevalence of impaired 
physical and cognitive functioning of about 13%.
Further results are tabulated in the Supplementary Material. 
Supplementary Table 4 shows the associations of modifiable risk fac-
tors with impaired physical and cognitive functioning with alternative 
adjustment to avoid potential collider and mediator effects. In addition 
to adjustment for demographic factors, the effects of health behaviors 
are mutually adjusted, and likewise, the effects of biomedical factors are 
mutually adjusted. Supplementary Tables 5–8 show sensitivity analyses 
using the LOCF method instead of multiple imputation. For impaired 
physical functioning (Supplementary Table 7), low fruit and vegeta-
ble consumption (OR 1.26 95% CI 1.04–1.52) and obesity (OR 1.79 
95% CI 1.34–2.38) were risk factors in the mutually adjusted model, 
but hypertension was not (OR 1.07, 95% CI 0.86–1.33). For impaired 
cognitive functioning (Supplementary Table 8) physical inactivity (OR 
1.24 95% CI 0.94–1.63) was not a risk factor, and obesity (OR 0.66 
95% CI 0.45–0.96) was protective in mutually adjusted analysis.
Discussion
We examined prospective associations between modifiable risk fac-
tors at age 50 years and age-related functional loss 18 years later: 
impaired physical functioning and impaired cognitive functioning. 
We found that physical inactivity, hypertension, and low FEV1 at 
age 50 years were each associated prospectively with both function-
ing outcomes after adjustment for the other candidate risk factors 
(for the physical inactivity–impaired cognitive functioning associa-
tion, adjusted p = .055). Depression and obesity at age 50 years were 
associated with risk of impaired physical functioning but not with 
impaired cognitive functioning. On the basis that our observations 
are causal with respect to physical and cognitive decline, physical 
inactivity, hypertension, and poor lung function around age 50 years 
appear to be important targets for prevention.
To our knowledge, this is the first study to compare modifia-
ble risk factor effects in both major functional domains, physical 
and cognitive (4). The novel evidence adds weight to the view that 
physical and cognitive functional declines can both potentially be 
prevented or delayed by midlife approaches to risk factor reduction 
(19). Our findings are observational and do not demonstrate revers-
ibility. However, intervention trials to date have recruited older par-
ticipants beyond the midlife stage, have not come within reach of the 
18-year period of follow-up in the present cohort study, and have 
focused on cognition decline rather than on functional decline more 
broadly (20). Our finding that hypertension was a robust risk factor 
for physical as well as cognitive impairments thus extends the trial 
evidence in respect of blood pressure reduction (2).
Observational data show that physical activity is protective for 
dementia (3,21). We add to the evidence that inactivity in midlife 
is also linked to increased risk for impaired physical functioning in 
later life. Our finding for impaired cognitive functioning was clear 
in the minimally adjusted analysis (OR 1.54 95% CI 1.23–1.93), 
remained significant in a model adjusted for demographics and 
health behaviors (Supplementary Table  4) but not after further 
adjustment for biomedical factors including some which may medi-
ate the benefits of physical activity into conserved cognition (OR 
1.28, 95% CI 0.99–1.65; Supplementary Table  3). Lung function 
and cognitive function have been shown to be correlated across the 
life course (22). Our prospective study presents a coherent picture, 
with physical inactivity and poor lung function each associated with 
future impairments in the physical and cognitive domains. Smoking 
at age 50 was associated with later impairments of physical func-
tioning after minimal adjustment but not after further adjustment 
for other factors including FEV1. The present null finding in respect 
of smoking and cognition could be due to competing risks (23,24).
We found the expected association of obesity with impairment 
in physical functioning, but no link with cognitive functioning (25). 
Current evidence is mixed: A recent large study challenges the con-
ventional view with findings that high BMI is a protective factor 
Figure 1. Prospective associations of modifiable risk factors at age 50 years 
with impaired physical and cognitive functioning in 2007–2009 or 2012–2013. 
N = 6,316. Model with mutual adjustment for all risk factors shown in the 
figurea, plus age, sex, ethnicity, education, marital status, and last known 
grade at age 50 years. ADL = activities of daily living; BMI = body mass index; 
CI = confidence interval; CRP = C-reactive protein; FEV1 = forced expiratory 
volume in 1 s; HDL  =  high-density lipoprotein; MMSE  =  Mini-Mental State 
Examination. aIncluding BMI but not obesity. bAll risk factors included in 
model, except BMI. cCorrected for height, measured at fourth clinic (2002–
2004). Missing risk factor data imputed using multiple imputation with 20 
imputations. Impaired physical functioning—at least one ADL. Impaired 
cognitive functioning—MMSE < 27. Some participants have both impaired 
physical and cognitive functioning. p Values = pairwise tests for heterogeneity 
using Cochran’s Q test.
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for cognitive impairment (26). Mixed findings were also obtained 
for depressive symptoms, which were associated with later impair-
ment of physical functioning, but not as anticipated with cognitive 
functioning (27). Many but not all of such prospective studies (28) 
involve participants considerably older at baseline than in the pre-
sent study. There was a modest association between CRP level and 
future impaired physical functioning, significant in the minimally but 
not mutually adjusted model. A cross-sectional association between 
CRP and physical performance measures has been observed, but the 
level did not predict change in performance in that study (29).
Key strengths of this study are the substantial risk factor expo-
sure data collected in midlife together with long follow-up. The base-
line of aging studies may be considerably later in the life course, 
and therefore Whitehall II is valuable for studies of exposure effects 
before or early in the processes leading to functional loss. Although 
the cohort is not representative of the general population in terms of 
risk factor distributions and health status, the associations of vascu-
lar risk factors are similar to those seen in community-based cohort 
studies and the effects we estimate in the present study are likely 
to be broadly generalizable (30). Notably, we found that the three 
risk factors that emerge as important determinants of age-related 
functioning were weakly correlated with one another (all Pearson 
correlation coefficients <.15).
There was a low prevalence of impaired cognitive function-
ing in our relatively young sample. Many studies use an MMSE 
score of less than 24 (31,32) to define impaired cognition. Here 
the score distribution led us to utilize the MMSE score less than 27 
cut point in order to increase sensitivity (12,33) (Supplementary 
Figure  2). Participants who satisfied our MMSE criterion were 
generally not severely cognitively impaired, and this may have 
contributed to type 2 errors (false positives) in estimates including 
the null relation with depressive symptoms and borderline asso-
ciation with physical activity (27). The relative youthfulness of 
the study sample has the advantage that dementia-related loss to 
follow-up is small.
To reduce potential bias in estimates of coefficients and their 
standard errors, we imputed missing values. We included many pre-
dictive auxiliary variables to reduce bias (18). To assess the valid-
ity of multiple imputation for handling missing data, we compared 
results based on imputation with those using the LOCF method as a 
sensitivity analysis. A few of the associations observed using multi-
ple imputation differed in the sensitivity analysis. In part, discrepan-
cies probably arose because the LOCF method assumes risk factor 
levels stay constant with increasing age. In this context, multiple 
imputation is the preferred approach for handling missing data. As 
expected, there was excess mortality among those lost to follow-up 
after age 50 (n = 702, hazard ratio 2.37 95% CI 1.9–3.0, adjusted 
for age, sex, and ethnicity). However, the group was only 10% of 
the target sample, and selection bias in the estimated associations is 
likely to be small. This study examines 12 risk factor effects based 
on pre-existing hypotheses. We checked for multiple testing and con-
firmed the reported associations except for one mutually adjusted 
association, between hypertension and cognitive impairment, which 
became marginally nonsignificant (34).
Delaying or preventing age-related functional impairments is a 
health policy research priority (19). Here we add to the sparse evidence 
that the same modifiable risk factors impact upon impaired physical 
and cognitive functioning in the same setting. Whether the interven-
tions take place in clinical or public health settings, or in both, this 
study suggests that blood pressure control, adequate physical activity, 
and maintenance of lung function should be at the centre of a uni-
fied prevention policy. It remains unclear how effective such policies 
could be. An early estimate attributed up to half the prevalence of 
Alzheimer’s disease to seven modifiable risk factors (diabetes, midlife 
hypertension, midlife obesity, physical inactivity, depression, smoking, 
and low educational attainment), whereas more recent calculations 
are more cautious (21,35). In the present study, there were impor-
tant excesses in crude prevalence of impaired physical and cognitive 
functioning, as defined, according to hypertension (5% excess), lung 
function below the first quintile (9% excess), and physical inactivity 
(about 12% excess) versus about 14% among the comparison groups.
In conclusion, our observational findings support the proposition 
that modifiable risk factor reduction in midlife may have benefit for 
maintaining global functioning in older people. We found support 
for blood pressure control, adequate physical activity, and mainte-
nance of lung function as key targets for delaying onset of impaired 
physical and cognitive functioning. Replication of our findings in 
other cohorts is needed, however, to support an evidence-based, uni-
fied approach to functional loss in older people.
Supplementary Material
Supplementary material can be found at: http://biomedgerontology.
oxfordjournals.org/
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